Bavarian Nordic

This study tests if the MVA-BN mpox vaccine made in a new type of cell works as well as the current version. About 970 healthy adults aged 18 to 49 will receive two doses. Researchers will measure immune response and check for side effects to ensure the new manufacturing method i…

This study tests the MVA-BN vaccine in 460 children aged 2 to 12 years to see if it safely prevents smallpox, mpox, and similar infections. Children receive two doses four weeks apart, and their immune response is compared to adults. The goal is to ensure the vaccine works and is…

This study tests a new vaccine designed to protect people from two viruses (VEEV and EEEV) that can cause severe brain swelling (encephalitis). About 411 healthy adults aged 18-50 will receive different doses of the vaccine or a placebo to find the safest and most effective dose.…